If detection of methylated BCAT1/IKZF1 ctDNA is to be useful in patient management, it is important to better understand the principles underlying the presence of these epigenetic markers in blood and how this relates to tissue expression and to tumour debulking. This evidence concerns the gene BCAT1 and neoplasm.